Dr. ASHIM GHATAK
 
  Deputy Director (Scientist F)
Division Of Clinical & Experimental Medicine
Central Drug Research Instiute
P O Box 173,
Lucknow- 226001 (India)
 
Phone No. 91-(0522)-2612411-18 , EXT. 4371
Fax No. 91-(0522)-2623405; 91-(0522)-2623938
E- Mail ashimghatak[at]yahoo dot com
Educational Qualifications MBBS; MD (Internal Medicine) ; Fellow Indian College of Physicians
Date of Birth

18.06.1957
Specializations (i) Clinical Medicine & Cardiology
(ii) Clinical Trials of New Drugs
Present activities and Area Clinical Trials
 
POST DOCTORAL EXPERIENCE
 
•
 Central Drug Research Institute, Lucknow, INDIA
 
RESEARCH EXPERIENCE
 
•
 Basic Research- 23 Years;
Applied Research- 18 Years
Teaching- 04 Years ( Undergraduate Medical and Post-Graduate Medical Teaching Experience)
Hospital Experience- 24 years
 
CURRENT AREAS OF INTEREST
 
•
 New Hypolipidemic Drug Development & Atherosclerosis Research
SIGNIFICANT CONTRIBUTIONS
 
Basic Research
Research in Oxidative Stress and role of Antioxidants in various cardiovascular syndromes and atherosclerosis culminating in research publications and an Award etc .
Product Development
Have been involved in development of various C D R I Drugs - Centimizone, Curcumin, Gugulipid, CDRI Compound 81/470, Injection Arteether and CDRI Compound 80/574.
 
SIGNIFICANT AWARDS
 
•
 “SHAKUNTALA AMIRCHAND AWARD ” 1996 in Cardiovascular Medicine” of the INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR).
•
 “K.G. NAIR ORATION 2003” of INDIAN SOCIETY OF HYPERTENSION , delivered on 13 February,2004 at the National conference held at Surat from 13th to 15th February, 2004
•
 Mrs JAL R VAKIL LECTURESHIP IN CARDIO- PULMONARY DISEASES - 2004” OF THE ASSOCIATION OF PHYSICIANS OF INDIA
•
 FELLOW OF THE INDIAN COLLEGE OF PHYSICIANS (F.I.C.P.) the academic body of ASSOCIATION of PHYSICIANS of INDIA(API) elected in 1997.
•
 "YOUNG SCIENTIST FROM DEVELOPING COUNTRY FELLOWSHIP" to attend CPT’92 World Conference of Clinical Pharmacology and Therapeutics at Yokohama , JAPAN in July, 1992.
 
SELECTED PUBLICATIONS
 
•
 Rajiv Nath, S Saxena , D Tewari, P Srivastava, A Ghatak, VC Pandey, RC Saxena.; Elevated superoxide anion levels in age related macular degeneration. -Annals of Ophthalmology (USA ) 2004 ;36(2); 111-114
•
 Chandra, M., Maurya, D.R., Kumar, S., Basara, H., Ghatak, A., Tekwani, B.L., Kaur, G., Misra, M.K. ; Reversible suppression of nitric oxide system in essential hypertension: Indian Journal of Clinical Biochemistry ; 2003 ; 18 (2) , 150-153
•
 M Chandra , HS Basera, S Mehrotra, T Sharma DR Maurya , A Ghatak , BL Tekwani, MK Misra ; Role of Nitric Oxide in essential hypertension.; Asia Pacific Journal of Pharmacology (Japan ); 14 ; 4; 2000 ; 139-142.
•
 M Chandra, K Surendra , RK Kapoor, A Ghatak, G Kaur, NR Pandey,MK Misra.; Oxidant stress mechanisms in heart failure.; Bollettino Chimico Farmaceutico (Italy); 2000 ; vol.139;No. 3;(110-113).
•
 Chandra M., Kumar A., Ghatak A., Singh P., Kapoor R.K., Saxena A.K.,Shanker K.; Platelet in pathogenesis of primary hypertension.; Biogenic Amines(Netherland); 1997 ; vol-13; no-6; (547-563).
•
 Ghatak A., Shankar K ., Singh P., Chandra M.; Serotonin: an ubiquitous neuromodulator in the failing heart; Asian Cardiovascular & Thoracic Annals (Singapore); 1998; Vol. 6;No.1; (11-16).
•
 Ghatak A., Shankar K ., Singh P., Chandra M.; Serotonin: an ubiquitous neuromodulator in the failing heart; Asian Cardiovascular & Thoracic Annals (Singapore); 1998; Vol. 6;No.1; (11-16).
•
 NV Nagaraja , SK Singh, JK Paliwal, A Ghatak, OP Asthana, RC Gupta; Preliminary pharmacokinetics of a new antihelminthic agent ,CDRI 81/470 in healthy subjects.; Int. J. of Pharmaceutics(USA)1998;Vol. 174; (117-124).
•
 Ghatak A. ; Heart failure,vitamin E and free radicals ; The Role of Nutrition in Medicine-The Clinical Pearls Yearbook1997 in Nutrition and Preventive Medicine. Editors- KR Robinson,J Eusuna, T Freytag & A Levy. Publishers- KR Hamilton & K Hamilton; IT Services, Sacramento, California, USA. (306-7).
•
 Ghatak A. , Brar M.J.S., Agarwal A., Goel N., Rastogi A.K., Vaish A.K., Sircar A.R., Chandra M. ; Oxy free radical system in Heart Failure and therapeutic role of oral Vitamin E; International Journal of Cardiology (USA); 1996 ; 57(2); (119-127).
•
 Chandra M., Gupta V., Rathi A.K., Vaish A.K., Srimal R.C., Pandey V.C., Ghatak A., Sircar A.R., Bhardwaj R.P.S., Singhal S.S.; Effect of Oral Vitamin-E on Oxy free radical status in acute myocardial infarction.; Asian Cardiovascular & Thoracic Annals (Singapore); 1995; No. 3 & 4 (117-122).
•
 Ghatak A., Bhatia K.B., Chandra A., Kapoor N.K.; Serum Cholesterol Binding reserve percentage in Diabetes mellitus.; Acta Diabetologica Latina; Vol.22, No.3; 1985;(253-258).
•
 Chandra M., Chandra N., Agarwal R., Kumar A., Ghatak A., Pandey V.C. The Free radical System in Ischemic heart Disease .; International J. of Cardiology(USA) ; 43; 1994; (121-125).
•
 Gupta R.R., Agarwal C.G., Singh G.P., Ghatak A.; Lipid lowering efficacy of Psyllium hydrophilic mucilloid in non insulin dependent diabetes mellitus with hyperlipidemia.; Ind. J. of Med. Research ; 100; 11 ;1994; (237-241).